Baudax Bio, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • R&D
    • Product Portfolio
    • ANJESO® (meloxicam) injection
    • NMB & Reversal Agent
    • Investigator Sponsored Research
  • Therapeutic Areas
    • Post-Operative Pain
    • Anesthesia
  • News & Investors
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Governance
    • Stock Info
    • Financial & Filings
  • Contact
  • Careers
×

Please see full Prescribing Information for ANJESO, including  Important Safety Information and Boxed Warning, at www.anjeso.com.

Press Releases

News & Investors

News & Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Governance
    • Governance Documents
    • Board of Directors
    • Board Committees
  • Stock Info
    • Form 8937
  • Financial & Filings
    • Overview
    • All SEC Filings

Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies

Nov 21, 2019 7:00am EST
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • Email Alerts
    • Tear Sheet
    • RSS News Feed
    © 2023 Baudax Bio, Inc. All Rights Reserved. ANJESO is a registered trademark of Baudax Bio, Inc.
    Privacy Policy Terms of Use Disclaimer Sitemap